Code No. | 製品名 | 販売中止日 | メーカー |
---|---|---|---|
B-NU844UCE | Anti-PMS2 mAb | 2020/03/31 | BIOGENEX |
B-NU826UC | Anti-Survivin mAb | 2020/03/31 | BIOGENEX |
B-NU822UC | Anti-CD11c mAb | 2020/03/31 | BIOGENEX |
B-NU821UC | Anti-Calponin-1 mAb | 2020/03/31 | BIOGENEX |
B-NU820UC | Anti-Ep-CAM mAb | 2020/03/31 | BIOGENEX |
B-NU816UC | Anti-MMP9 mAb | 2020/03/31 | BIOGENEX |
B-NU814UC | Anti-CD14 mAb | 2020/03/31 | BIOGENEX |
B-NU813UC | Anti-MUC1 mAb | 2020/03/31 | BIOGENEX |
B-NU782UC | Anti-ERG (Est-Related Gene) mAb | 2020/03/31 | BIOGENEX |
B-NU778UC | Anti-Beta-Catenin mAb | 2020/03/31 | BIOGENEX |
B-NU769UC | Anti-CD38 mAb | 2020/03/31 | BIOGENEX |
B-NU757UC | Anti-CD82 (KAI1) mAb | 2020/03/31 | BIOGENEX |
B-NU750UC | Anti-Mum1 (IRF4) mAb | 2020/03/31 | BIOGENEX |
B-AR7985R | Anti-FLI1 pAb | 2020/03/31 | BIOGENEX |
B-AR7595R | Anti-CD117 (c-Kit) pAb | 2020/03/31 | BIOGENEX |
B-AN8515M | Anti-CD11b/ITAM mAb | 2020/03/31 | BIOGENEX |
B-AN8475M | Anti-Cytokeratin 5 mAb | 2020/03/31 | BIOGENEX |
B-AN8445ME | Anti-PMS2 mAb | 2020/03/31 | BIOGENEX |
B-AN8375M | Anti-CD138 mAb | 2020/03/31 | BIOGENEX |
B-AN8345M | Anti-MCM2 mAb | 2020/03/31 | BIOGENEX |
B-AN8335M | Anti-SOX2 mAb | 2020/03/31 | BIOGENEX |
B-AN8305M | Anti-Oct 2 mAb | 2020/03/31 | BIOGENEX |
B-AN8265M | Anti-Survivin mAb | 2020/03/31 | BIOGENEX |
B-AN8225M | Anti-CD11c mAb | 2020/03/31 | BIOGENEX |
B-AN8215M | Anti-Calponin-1 mAb | 2020/03/31 | BIOGENEX |
B-AN8145M | Anti-CD14 mAb | 2020/03/31 | BIOGENEX |
B-AN8135M | Anti-MUC1 mAb | 2020/03/31 | BIOGENEX |
B-AN7875M | Anti-Luteinizing Hormone (LH) mAb | 2020/03/31 | BIOGENEX |
B-AN7825M | Anti-ERG (Est-Related Gene) mAb | 2020/03/31 | BIOGENEX |
B-AN7785M | Anti-Beta-Catenin mAb | 2020/03/31 | BIOGENEX |
B-AN7575M | Anti-CD82 (KAI1) mAb | 2020/03/31 | BIOGENEX |
B-AN7465M | Anti-PTEN mAb | 2020/03/31 | BIOGENEX |
MEX004-6 | Anti-CD326 (EpCAM) mAb-Biotin | 2020/03/31 | MBL |
B-NU815UC | Anti-Cyclin D1 mAb | 2020/03/31 | BIOGENEX |
B-NU856UC | Anti-GCDFP-15 mAb | 2020/03/31 | BIOGENEX |
B-AN8565M | Anti-GCDFP-15 mAb | 2020/03/31 | BIOGENEX |
B-AN7385M | Anti-NGFR mAb | 2020/03/31 | BIOGENEX |
B-AN7375M | Anti-CD205 mAb | 2020/03/31 | BIOGENEX |
B-AN7325M | Anti-CD41 mAb | 2020/03/31 | BIOGENEX |
B-AN7295M | Anti-CD19 mAb | 2020/03/31 | BIOGENEX |
B-AN7255M | Anti-E-Cadherin mAb | 2020/03/31 | BIOGENEX |
B-AN7245M | Anti-Oct 4 mAb | 2020/03/31 | BIOGENEX |
B-AN7225M | Anti-CD4 mAb | 2020/03/31 | BIOGENEX |
B-AN7165M | Anti-CD146 mAb | 2020/03/31 | BIOGENEX |
B-AN7145M | Anti-PSMA (Prostate Specific Membrane Antigen) mAb | 2020/03/31 | BIOGENEX |
B-AM7085M | Anti-Bcl-6 mAb | 2020/03/31 | BIOGENEX |
101G | Anti-Whole Serum (Human) pAb | 2020/03/31 | MBL |
101R | Anti-Whole Serum (Human) pAb | 2020/03/31 | MBL |
103AG | Anti-IgG (γ chain) (Human) pAb | 2020/03/31 | MBL |
103AR | Anti-IgG (γ chain) (Human) pAb | 2020/03/31 | MBL |
103R | Anti-IgG (H+L chain) (Human) pAb | 2020/03/31 | MBL |
105G | Anti-IgA (α chain) (Human) pAb | 2020/03/31 | MBL |
105R | Anti-IgA (α chain) (Human) pAb | 2020/03/31 | MBL |
106G | Anti-IgA (α chain) (Human) pAb-FITC | 2020/03/31 | MBL |
107G | Anti-IgM (µ chain) (Human) pAb | 2020/03/31 | MBL |
107R | Anti-IgM (µ chain) (Human) pAb | 2020/03/31 | MBL |
108G | Anti-IgM (µ chain) (Human) pAb-FITC | 2020/03/31 | MBL |
109 | Anti-IgD (δ chain) (Human) pAb | 2020/03/31 | MBL |
114 | Anti-IgE (ε chain) (Human) pAb-FITC | 2020/03/31 | MBL |
116 | Anti-IgG+IgA+IgM (H+L chain) (Human) pAb-FITC | 2020/03/31 | MBL |
119R | Anti-C4 (β1E) (Human) pAb | 2020/03/31 | MBL |
120 | Anti-C4 (β1E) (Human) pAb-FITC | 2020/03/31 | MBL |
124 | Anti-C1q (Human) pAb-FITC | 2020/03/31 | MBL |
136 | Anti-Fibrinogen (Human) pAb-FITC | 2020/03/31 | MBL |
137 | Anti-Ceruloplasmin (Human) pAb | 2020/03/31 | MBL |
141 | Anti-Haptoglobin (Human) pAb | 2020/03/31 | MBL |
159 | Anti-Ig κ (L chain) (Human) pAb | 2020/03/31 | MBL |
161 | Anti-Ig λ (L chain) (Human) pAb | 2020/03/31 | MBL |
169A | Anti-Hemoglobin A (Human) pAb | 2020/03/31 | MBL |
206 | Anti-IgG (H+L chain) (Human) pAb-HRP | 2020/03/31 | MBL |
208 | Anti-IgG (γ chain) (Human) pAb-HRP | 2020/03/31 | MBL |
210 | Anti-IgA (α chain) (Human) pAb-HRP | 2020/03/31 | MBL |
216 | Anti-IgA (α chain) (Human) pAb-FITC | 2020/03/31 | MBL |
218 | Anti-IgM (µ chain) (Human) pAb-FITC | 2020/03/31 | MBL |
220 | Anti-IgD (δ chain) (Human) pAb-FITC | 2020/03/31 | MBL |
232 | Anti-IgG (H+L chain) (Human) pAb-FITC | 2020/03/31 | MBL |
234 | Anti-IgG (H+L chain) (Rabbit) pAb-FITC | 2020/03/31 | MBL |
238 | Anti-IgG (H+L chain) (Mouse) pAb-FITC | 2020/03/31 | MBL |
354 | Anti-IgG (H+L chain) (Rat) pAb-FITC | 2020/03/31 | MBL |
525 | Anti-IgG (H+L chain) (Bovine) pAb | 2020/03/31 | MBL |
527 | Anti-Albumin (Bovine) pAb | 2020/03/31 | MBL |
544 | Anti-IgG (H+L chain) (Goat) pAb-FITC | 2020/03/31 | MBL |
B-AC6015M | Anti-p16 + Ki67 Cocktail mAb | 2020/03/31 | BIOGENEX |
B-AM0015M | Anti-Melanoma mAb | 2020/03/31 | BIOGENEX |
B-AM0125M | Anti-Myoglobin mAb | 2020/03/31 | BIOGENEX |
B-AM0135ME | Anti-PSAP mAb | 2020/03/31 | BIOGENEX |
B-AM0335M | Anti-TSH mAb | 2020/03/31 | BIOGENEX |
B-AM034A5M | Anti-Thyroxine mAb | 2020/03/31 | BIOGENEX |
B-AM0735M | Anti-Neurofilament mAb | 2020/03/31 | BIOGENEX |
B-AM0905M | Anti-Actin, Muscle Specific mAb | 2020/03/31 | BIOGENEX |
B-AM1265M | Anti-Chromogranin A mAb | 2020/03/31 | BIOGENEX |
B-AM1285M | Anti-Actin, Smooth Muscle mAb | 2020/03/31 | BIOGENEX |
B-AM1325M | Anti-Cytokeratin 13 mAb | 2020/03/31 | BIOGENEX |
B-AM1355M | Anti-BCA225 mAb | 2020/03/31 | BIOGENEX |
B-AM1425M | Anti-Cytokeratin 8 mAb | 2020/03/31 | BIOGENEX |
B-AM1465M | Anti-Cytokeratin 14 mAb | 2020/03/31 | BIOGENEX |
B-AM2225ME | Anti-Epstein-Barr Virus (EBV) Early Antigen mAb | 2020/03/31 | BIOGENEX |
B-AM2285M | Anti-PLAP mAb | 2020/03/31 | BIOGENEX |
B-AM2315M | Anti-BLA36 mAb | 2020/03/31 | BIOGENEX |
B-AM2325M | Anti-CD31 (Endothelial Cell) mAb | 2020/03/31 | BIOGENEX |